Your browser doesn't support javascript.
loading
Paeoniflorin ameliorates antipsychotic-induced hyperprolactinemia in rats by attenuating impairment of the dopamine D2 receptor and TGF-ß1 signaling pathways in the hypothalamus and pituitary.
Huang, Xiaoqian; Ren, Liying; Hou, Lianbing; Fan, Hua; Wang, Chengliang; Wang, Chunxia; Li, Yuhao.
Affiliation
  • Huang X; Department of Pharmacy, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China. Electronic address: 302804664@qq.com.
  • Ren L; Department of Pharmacy, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China. Electronic address: 1775885301@qq.com.
  • Hou L; Department of Pharmacy, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China. Electronic address: houlianbing@163.com.
  • Fan H; Department of Pharmacy, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China. Electronic address: fanhua009@163.com.
  • Wang C; Department of Pharmacy, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China. Electronic address: 863884159@qq.com.
  • Wang C; Department of Pharmacy, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China; Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, 510515, China. Electronic address: wangcx@smu.edu.cn.
  • Li Y; Department of Pharmacy, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China; Endocrinology and Metabolism Group, Sydney Institute of Health Sciences/Sydney Institute of Traditional Chinese Medicine, NSW, 2000 Australia. Electronic address: yuhao@sitcm.edu.au.
J Ethnopharmacol ; 257: 112862, 2020 Jul 15.
Article in En | MEDLINE | ID: mdl-32294507
ABSTRACT
ETHNOPHARMACOLOGICAL RELEVANCE Paeoniflorin, a prominent component in some Chinese formulas for hyperprolactinemia-associated disorders, has been found to inhibit prolactin secretion in prolactinoma cells.

AIM:

To examine the efficacy of paeoniflorin on hyperprolactinemia and the underlying mechanisms of action. MATERIALS AND

METHODS:

Hyperprolactinemia in female rats was generated by administration of olanzapine (5 mg/kg, by a gavage method, once daily, × 13 weeks). The rats were co-treated with paeoniflorin (10 and 50 mg/kg). Prolactin and TGF-ß1 concentrations were detected by ELISA. Protein expression was determined by Western blot. The effect in MMQ cells was also examined.

RESULTS:

Paeoniflorin inhibited olanzapine-induced increases in plasma prolactin concentration and prolactin protein overexpression in the pituitary and hypothalamus of rats. Further, paeoniflorin restored olanzapine-induced downregulation of pituitary and hypothalamic dopamine D2 receptor (D2R) protein expression. More importantly, paeoniflorin attenuated olanzapine-suppressed protein expression of transforming growth factor (TGF)-ß1 and its downstream genes, type II TGF-ß receptor, type I TGF-ß receptor and phosphorylated SMAD3 in the tissues. However, paeoniflorin did not affect plasma TGF-ß1 concentration and hepatic TGF-ß1 protein expression. In accord, olanzapine-induced increase in prolactin concentration, upregulation of prolactin protein expression, and downregulation of protein expression of the D2R and TGF-ß1 signals in MMQ cells were attenuated.

CONCLUSIONS:

This study demonstrates that paeoniflorin ameliorates olanzapine-induced hyperprolactinemia in rats by attenuating impairment of the D2R and TGF-ß1 signaling pathways in the hypothalamus and pituitary. Our findings may provide evidence to support the use of paeoniflorin-contained Chinese herbs and formulas for hyperprolactinemia and its associated disorders.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Pituitary Gland / Prolactin / Hyperprolactinemia / Receptors, Dopamine D2 / Monoterpenes / Transforming Growth Factor beta1 / Glucosides / Hypothalamus Type of study: Prognostic_studies Language: En Journal: J Ethnopharmacol Year: 2020 Type: Article

Full text: 1 Database: MEDLINE Main subject: Pituitary Gland / Prolactin / Hyperprolactinemia / Receptors, Dopamine D2 / Monoterpenes / Transforming Growth Factor beta1 / Glucosides / Hypothalamus Type of study: Prognostic_studies Language: En Journal: J Ethnopharmacol Year: 2020 Type: Article